ijms-logo

Journal Browser

Journal Browser

Molecular Biology of Cancer Stem Cells

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Biology".

Deadline for manuscript submissions: closed (31 December 2018) | Viewed by 5172

Special Issue Editor


E-Mail Website
Guest Editor
Department of Cell Biology, Research Institute for Microbial Diseases, Osaka University, 3-1, Yamadaoka, Suita, Osaka 565-0871, Japan
Interests: cancer stem cells; developmental biology; germ cells; molecular therapeutics; embryonic stem cells; regenerative medicine

Special Issue Information

Dear Colleagues,

Cancer tissues basically consist of a heterogeneous cell population, in which small subpopulations of cancer stem cells (CSCs) are present. CSCs were initially shown in the bone marrow of AML patients and have since been identified in various solid tumors of cancers. Like normal stem cells, CSCs have a long lifetime and show quiescent characteristics of the dormant state within a special microenvironment. CSCs have the capacity for self-renewal, giving rise to undifferentiated and differentiated cancer cells in response to altered microenvironmental stimuli.

In addition, CSCs are highly resistant to apoptosis and chemotherapy. Therefore, the presence of CSCs makes cancer treatment difficult. Although treatment strategies targeting CSCs are expected, there is no consensus regarding CSC phenotype from different tumor types. Therefore, molecular targeted treatment is difficult. In this situation, it is necessary to understand previously known properties of CSCs and further elucidate the characteristics of CSCs.

The Special Issue, entitled "Molecular Biology of Cancer Stem Cells", aims to provide a research platform for the collection of the latest original and review articles covering molecular biological studies of factors related to the control of CSC characteristics and action mechanisms of anti-cancer drugs which are targeted them.

Associate Prof. Dr. Masami Nozaki
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Proliferation
  • Sphere formation
  • Apoptosis
  • Metastasis
  • Epithelial-to-mesenchymal transition
  • Recurrence
  • Microenvironment
  • Targeted drugs

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

17 pages, 4152 KiB  
Article
Novel Gastric Cancer Stem Cell-Related Marker LINGO2 Is Associated with Cancer Cell Phenotype and Patient Outcome
by Jung Hyun Jo, Soo Been Park, Semi Park, Hee Seung Lee, Chanyang Kim, Dawoon E. Jung and Si Young Song
Int. J. Mol. Sci. 2019, 20(3), 555; https://doi.org/10.3390/ijms20030555 - 28 Jan 2019
Cited by 23 | Viewed by 4888
Abstract
The expression of leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 2 (LINGO2) has been reported in Parkinson’s disease; however, its role in other diseases is unknown. Gastric cancer is the second leading cause of cancer death. Cancer stem cells (CSC) are a [...] Read more.
The expression of leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 2 (LINGO2) has been reported in Parkinson’s disease; however, its role in other diseases is unknown. Gastric cancer is the second leading cause of cancer death. Cancer stem cells (CSC) are a subpopulation of cancer cells that contribute to the initiation and invasion of cancer. We identified LINGO2 as a CSC-associated protein in gastric cancers both in vitro and in patient-derived tissues. We studied the effect of LINGO2 on cell motility, stemness, tumorigenicity, and angiogenic capacity using cells sorted based on LINGO2 expression and LINGO2-silenced cells. Tissue microarray analysis showed that LINGO2 expression was significantly elevated in advanced gastric cancers. The overall survival of patients expressing high LINGO2 was significantly shorter than that of patients with low LINGO2. Cells expressing high LINGO2 showed elevated cell motility, angiogenic capacity, and tumorigenicity, while LINGO2 silencing reversed these properties. Silencing LINGO2 reduced kinase B (AKT)/extracellular signal-regulated kinase (ERK)/ERK kinase (MEK) phosphorylation and decreased epithelial-mesenchymal transition (EMT)-associated markers—N-Cadherin and Vimentin and stemness-associated markers— POU class 5 homeobox 1 (OCT4) and Indian hedgehog (IHH), and markedly decreased the CD44+ population. These indicate the involvement of LINGO2 in gastric cancer initiation and progression by altering cell motility, stemness, and tumorigenicity, suggesting LINGO2 as a putative target for gastric cancer treatment. Full article
(This article belongs to the Special Issue Molecular Biology of Cancer Stem Cells)
Show Figures

Graphical abstract

Back to TopTop